Biotech Firm BillionToOne Shares Surge 67% on $273M IPO
Molecular-diagnostics startup BillionToOne raised $273 million in an oversubscribed IPO, with shares jumping 67% at debut and valuing the company at around $4.4 billion.
#HealthTech
Explore MarketSpeaker's latest reporting, research, and expert analysis tagged with "health tech", collected in one continuously updated archive.
Related Posts